Suppr超能文献

Alternative Strategies in Thalassemia: Focus on Thalidomide.

作者信息

Naithani R, Jeyaraman P, Mahapatra M

机构信息

New Delhi, India.

出版信息

Indian J Hematol Blood Transfus. 2020 Apr;36(2):227-228. doi: 10.1007/s12288-020-01285-w. Epub 2020 May 5.

Abstract
摘要

相似文献

1
Alternative Strategies in Thalassemia: Focus on Thalidomide.
Indian J Hematol Blood Transfus. 2020 Apr;36(2):227-228. doi: 10.1007/s12288-020-01285-w. Epub 2020 May 5.
2
Investigating the Efficacy and Safety of Thalidomide for Treating Patients With -Thalassemia: A Meta-Analysis.
Front Pharmacol. 2022 Jan 11;12:814302. doi: 10.3389/fphar.2021.814302. eCollection 2021.
4
Thalidomide has a significant effect in patients with thalassemia intermedia.
Hematology. 2018 Jan;23(1):50-54. doi: 10.1080/10245332.2017.1354427. Epub 2017 Jul 18.
5
Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia.
Front Pharmacol. 2020 Jul 24;11:1137. doi: 10.3389/fphar.2020.01137. eCollection 2020.
7
Thalidomide for Patients with β-Thalassemia: A Multicenter Experience.
Mediterr J Hematol Infect Dis. 2020 May 1;12(1):e2020021. doi: 10.4084/MJHID.2020.021. eCollection 2020.
8
The association of HBG2, BCL11A, and HBS1L-MYB polymorphisms to thalidomide response in Chinese β-thalassemia patients.
Blood Cells Mol Dis. 2020 Sep;84:102442. doi: 10.1016/j.bcmd.2020.102442. Epub 2020 Apr 26.
9
A Phase 2 Randomized Controlled Trial of Single-Agent Hydroxyurea Versus Thalidomide Among Adult Transfusion Dependent β Thalassemia Patients.
Indian J Hematol Blood Transfus. 2023 Apr;39(2):266-275. doi: 10.1007/s12288-022-01620-3. Epub 2023 Jan 3.
10
Evaluation of the combination therapy of hydroxyurea and thalidomide in β-thalassemia.
Blood Adv. 2022 Dec 27;6(24):6162-6168. doi: 10.1182/bloodadvances.2022007031.

本文引用的文献

1
Thalidomide in Patients with Transfusion-Dependent E-Beta Thalassemia Refractory to Hydroxyurea: A Single-Center Experience.
Indian J Hematol Blood Transfus. 2020 Apr;36(2):399-402. doi: 10.1007/s12288-020-01263-2. Epub 2020 Mar 2.
2
Promising Response to Thalidomide in Symptomatic β-Thalassemia.
Indian J Hematol Blood Transfus. 2020 Apr;36(2):337-341. doi: 10.1007/s12288-019-01231-5. Epub 2019 Nov 18.
4
Spectrum of Hemoglobinopathies: A New Revelation in a Tertiary Care Hospital of Odisha.
Indian J Hematol Blood Transfus. 2019 Jul;35(3):513-517. doi: 10.1007/s12288-018-1052-8. Epub 2018 Dec 1.
5
Fetal Hemoglobin Induction by Epigenetic Drugs.
Semin Hematol. 2018 Apr;55(2):60-67. doi: 10.1053/j.seminhematol.2018.04.008. Epub 2018 Apr 22.
6
A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?
Blood Rev. 2018 Jul;32(4):300-311. doi: 10.1016/j.blre.2018.02.001. Epub 2018 Feb 12.
7
Thalidomide has a significant effect in patients with thalassemia intermedia.
Hematology. 2018 Jan;23(1):50-54. doi: 10.1080/10245332.2017.1354427. Epub 2017 Jul 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验